Comprehensive symptom assessment using Integrated Palliative care Outcome Scale in hospitalized heart failure patients
- PMID: 35307988
- PMCID: PMC9065822
- DOI: 10.1002/ehf2.13907
Comprehensive symptom assessment using Integrated Palliative care Outcome Scale in hospitalized heart failure patients
Abstract
Aims: Patients with heart failure (HF) may have variable unrecognized symptom burdens. We sought to investigate the details, determinants, and prognostic significance of symptom burden in hospitalized patients with HF.
Methods and results: We prospectively evaluated consecutive hospitalized patients with HF as primary diagnosis at our institution using the Integrated Palliative care Outcome Scale (IPOS) both on admission and at discharge. The IPOS, which is a well-validated multi-dimensional symptom assessment scale among advanced illness, consists of 17 questions for enquiring about physical symptoms (10 items), emotional symptoms (4 items) and communication and practical issues (3 items) using a 5-point Likert scale (0 [best]-4 [worst] points). Clinically relevant symptoms were defined as ≥2 points for each IPOS item. Worsening symptom burden was defined as the total IPOS score at discharge being poorer than that on admission. Of 294 patients (mean age: 77.5 ± 12.0 years, male: 168 patients, New York Heart Association class IV: 96 patients, mean left ventricular ejection fraction [LVEF]: 44%, and median N-terminal pro B-type natriuretic peptide [NT-proBNP] level: 4418 ng/L), the median (IQR) total IPOS score on admission was 19 (12, 27) and they were widely distributed (minimum: 0 - maximum: 52). The total IPOS score on admission was not correlated with the HF severity, including LVEF (Spearman's ρ = -0.05, P = 0.43), NT-proBNP levels (Spearman's ρ = 0.08, P = 0.20) or in-hospital mortality prediction model (GWTG-HF risk score) (Spearman's ρ = 0.01, P = 0.90). Total IPOS scores significantly decreased during hospitalization as a whole (median [IQR]: 13 [6, 21] at discharge; P < 0.001 vs. those on admission). All of the four emotional symptoms (patient anxiety, depression, family anxiety and feeling at peace) remained in the top 5 of clinically relevant symptoms at discharge, whereas none of 10 physical symptoms were nominated. Worsening symptom burden was noted in 28% of the patients during hospitalization, and was independently associated with higher all-cause mortality after discharge (hazard ratio: 2.28, 95% confidence interval: 1.02-5.09; P = 0.044) even after adjustment by age and HF mortality prediction model (MAGGIC risk score).
Conclusions: We revealed that hospitalized patients with HF had multi-dimensional symptom burdens which varied among individuals and were not correlated with the disease severity. Emotional symptoms, such as anxiety and depression, were the main clinically relevant symptoms at discharge. A worsening IPOS score was noted in a quarter of patients with HF and was associated with a poor prognosis, suggesting the importance of holistic symptom assessment during the course of hospitalization for HF.
Keywords: Heart failure; Integrated Palliative care Outcome Scale; Psychological symptoms.
© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Conflict of interest statement
All authors reported that they have no relationships relevant to the content of this paper to disclose.
Figures





Similar articles
-
Validation of a Supportive and Palliative Care Indicator Tool Among Patients Hospitalized Due to Heart Failure.J Card Fail. 2025 Jan;31(1):16-25. doi: 10.1016/j.cardfail.2024.04.016. Epub 2024 May 10. J Card Fail. 2025. PMID: 38735621
-
Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.PLoS One. 2018 Nov 28;13(11):e0206380. doi: 10.1371/journal.pone.0206380. eCollection 2018. PLoS One. 2018. PMID: 30485284 Free PMC article.
-
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.Circ Heart Fail. 2021 Dec;14(12):e008837. doi: 10.1161/CIRCHEARTFAILURE.121.008837. Epub 2021 Nov 22. Circ Heart Fail. 2021. PMID: 34802253
-
Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction.Clin Cardiol. 2022 Jun;45 Suppl 1(Suppl 1):S40-S51. doi: 10.1002/clc.23849. Clin Cardiol. 2022. PMID: 35789014 Free PMC article. Review.
-
Developing a core outcome set for patient-reported symptom monitoring to reduce hospital admissions for patients with heart failure.Eur J Cardiovasc Nurs. 2022 Nov 23;21(8):830-839. doi: 10.1093/eurjcn/zvac019. Eur J Cardiovasc Nurs. 2022. PMID: 35404418
Cited by
-
Palliative Care Needs Assessment Using the Surprise Question in Hospitalized Patients With Heart Failure.J Am Heart Assoc. 2025 Apr 15;14(8):e037769. doi: 10.1161/JAHA.124.037769. Epub 2025 Mar 30. J Am Heart Assoc. 2025. PMID: 40159709 Free PMC article.
-
Mediation by Fatalism of the Association Between Symptom Burden and Self-care Management in Patients With Heart Failure.J Cardiovasc Nurs. 2024 May-Jun 01;39(3):229-236. doi: 10.1097/JCN.0000000000001053. Epub 2023 Oct 13. J Cardiovasc Nurs. 2024. PMID: 37830904 Free PMC article.
References
-
- Yasuda S, Miyamoto Y, Ogawa H. Current status of cardiovascular medicine in the Aging Society of Japan. Circulation 2018; 138: 965–967. - PubMed
-
- Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, Murray SA, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker SD, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J. Advanced Heart Failure Study Group of the HFA of the ESC. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of cardiology. Eur J Heart Fail 2009; 11: 433–443. - PubMed
-
- Anzai T, Sato T, Fukumoto Y, Izumi C, Kizawa Y, Koga M, Nishimura K, Ohishi M, Sakashita A, Sakata Y, Shiga T, Takeishi Y, Yasuda S, Yamamoto K, Abe T, Akaho R, Hamatani Y, Hosoda H, Ishimori N, Kato M, Kinugasa Y, Kubozono T, Nagai T, Oishi S, Okada K, Shibata T, Suzuki A, Suzuki T, Takagi M, Takada Y, Tsuruga K, Yoshihisa A, Yumino D, Fukuda K, Kihara Y, Saito Y, Sawa Y, Tsutsui H, Kimura T. JCS/JHFS 2021 Statement on Palliative Care in Cardiovascular Diseases. Circ J 2021; 85: 695–757. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous